| A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma P van der Bruggen, C Traversari, P Chomez, C Lurquin, E De Plaen, ... Science 254 (5038), 1643-1647, 1991 | 4711 | 1991 |
| Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational … H von der Maase, SW Hansen, JT Roberts, L Dogliotti, T Oliver, MJ Moore, ... Journal of clinical oncology 41 (23), 3881-3890, 2023 | 2553 | 2023 |
| Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses S Gnjatic, D Atanackovic, E Jäger, M Matsuo, A Selvakumar, NK Altorki, ... Proceedings of the National Academy of Sciences 100 (15), 8862-8867, 2003 | 976 | 2003 |
| Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft … SE Al-Batran, JT Hartmann, S Probst, H Schmalenberg, S Hollerbach, ... Journal of clinical oncology 26 (9), 1435-1442, 2008 | 960 | 2008 |
| Simultaneous humoral and cellular immune response against cancer–testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2–binding peptide epitopes E Jäger, YT Chen, JW Drijfhout, J Karbach, M Ringhoffer, D Jäger, ... The Journal of experimental medicine 187 (2), 265-270, 1998 | 938 | 1998 |
| A survey of the humoral immune response of cancer patients to a panel of human tumor antigens E Stockert, E Jäger, YT Chen, MJ Scanlan, I Gout, J Karbach, M Arand, ... The Journal of experimental medicine 187 (8), 1349-1354, 1998 | 909 | 1998 |
| Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3 M Marchand, P Weynants, E Rankin, F Arienti, F Belli, G Parmiani, ... International Journal of Cancer 63 (6), 883-885, 1995 | 593 | 1995 |
| Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers E Jäger, S Gnjatic, Y Nagata, E Stockert, D Jäger, J Karbach, A Neumann, ... Proceedings of the National Academy of Sciences 97 (22), 12198-12203, 2000 | 577 | 2000 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 546 | 2014 |
| Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation A Gupta, HC Probst, V Vuong, A Landshammer, S Muth, H Yagita, ... The Journal of Immunology 189 (2), 558-566, 2012 | 438 | 2012 |
| NY‐ESO‐1: review of an immunogenic tumor antigen S Gnjatic, H Nishikawa, AA Jungbluth, AO Güre, G Ritter, E Jäger, A Knuth, ... Advances in cancer research 95, 1-30, 2006 | 428 | 2006 |
| Selective survival of naturally occurring human CD4+ CD25+ Foxp3+ regulatory T cells cultured with rapamycin L Strauss, TL Whiteside, A Knights, C Bergmann, A Knuth, A Zippelius The Journal of Immunology 178 (1), 320-329, 2007 | 423 | 2007 |
| Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library YT Chen, AO Güre, S Tsang, E Stockert, E Jäger, A Knuth, LJ Old Proceedings of the National Academy of Sciences 95 (12), 6919-6923, 1998 | 414 | 1998 |
| Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma E Jäger, M Ringhoffer, M Altmannsberger, M Arand, J Karbach, D Jäger, ... International journal of cancer 71 (2), 142-147, 1997 | 409 | 1997 |
| Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses E Jager, Y Nagata, S Gnjatic, H Wada, E Stockert, J Karbach, PR Dunbar, ... Proceedings of the National Academy of Sciences of the United States of …, 2000 | 395 | 2000 |
| Granulocyte‐macrophage‐colony‐stimulating factor enhances immune responses to melanoma‐associated peptides in vivo E Jäger, M Ringhoffer, HP Dienes, M Arand, J Karbach, D Jäger, ... International journal of cancer 67 (1), 54-62, 1996 | 376 | 1996 |
| Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic‐T‐cell responses: Evidence for immunoselection of antigen … E Jäger, M Ringhoffer, J Karbach, M Arand, F Oesch, A Knuth International Journal of Cancer 66 (4), 470-476, 1996 | 363 | 1996 |
| Expression of MAGE genes in primary and metastatic cutaneous melanoma F Brasseur, D Rimoldi, D Liénard, B Lethé, S Carrel, F Arienti, L Suter, ... International journal of cancer 63 (3), 375-380, 1995 | 358 | 1995 |
| T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. A Knuth, B Danowski, HF Oettgen, LJ Old Proceedings of the National Academy of Sciences 81 (11), 3511-3515, 1984 | 344 | 1984 |
| SSX: A multigene family with several members transcribed in normal testis and human cancer AO Gure, Ö Türeci, U Sahin, S Tsang, MJ Scanlan, E Jäger, A Knuth, ... International journal of cancer 72 (6), 965-971, 1997 | 315 | 1997 |
